Bionet (1784) — Cash Flow Reinvestment Rate
Bionet (1784) has a Cash Flow Reinvestment Rate of 1.19x as of June 2026, reinvesting NT$60.75 Million (capex NT$10.14 Million plus investments NT$-50.60 Million) from operating cash flow of NT$51.22 Million. See 1784 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Bionet Cash Flow Reinvestment Rate (2019–2025)
Historical reinvestment intensity for Bionet across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Bionet.
Annual Cash Flow Reinvestment Rate for Bionet (2019–2025)
Year-by-year capital reinvestment analysis for Bionet. See 1784 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TWD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.04x | NT$302.51 Million | NT$148.04 Million | NT$132.18 Million | ▼ -53.3% |
| 2024 | 4.38x | NT$772.28 Million | NT$176.49 Million | NT$103.49 Million | ▲ +53.6% |
| 2023 | 2.85x | NT$436.21 Million | NT$153.09 Million | NT$26.28 Million | ▲ +653.0% |
| 2022 | 0.38x | NT$35.82 Million | NT$94.65 Million | NT$32.91 Million | ▼ -82.4% |
| 2021 | 2.15x | NT$29.80 Million | NT$13.88 Million | NT$16.66 Million | ▲ +101.9% |
| 2020 | 1.06x | NT$78.35 Million | NT$73.66 Million | NT$38.03 Million | ▼ -95.0% |
| 2019 | 21.27x | NT$56.78 Million | NT$2.67 Million | NT$11.60 Million | — |